scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1031746570 |
P356 | DOI | 10.1038/SREP21422 |
P8608 | Fatcat ID | release_g4chqk4qaveythw63tislvvxye |
P932 | PMC publication ID | 4757825 |
P698 | PubMed publication ID | 26888011 |
P5875 | ResearchGate publication ID | 295089034 |
P50 | author | Bruce K. Gale | Q39476061 |
Li Zhang | Q43714779 | ||
P2093 | author name string | Yi Zhao | |
Jiao Chen | |||
Yan Deng | |||
Tao Tang | |||
Jun Hu | |||
Xiaohui Yan | |||
Himanshu J Sant | |||
Kwongwai Choy | |||
P2860 | cites work | Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays | Q30524055 |
Gene Silencing in Skin After Deposition of Self-Delivery siRNA With a Motorized Microneedle Array Device | Q30578477 | ||
Increased interstitial pressure improves nucleic acid delivery to skin enabling a comparative analysis of constitutive promoters | Q33576601 | ||
Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies | Q33712814 | ||
First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. | Q33730680 | ||
Effect of microneedle design on pain in human volunteers | Q34048990 | ||
Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD) | Q34209790 | ||
Elimination pathways of systemically delivered siRNA. | Q34556940 | ||
RNAi therapeutics: principles, prospects and challenges | Q34621268 | ||
Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin | Q35090493 | ||
Microneedles for transdermal drug delivery | Q35690686 | ||
Microneedles for drug and vaccine delivery | Q36164749 | ||
Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model. | Q36482238 | ||
Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept | Q36674114 | ||
Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. | Q38177110 | ||
A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy". | Q38242733 | ||
Therapeutic face of RNAi: in vivo challenges | Q38268541 | ||
siRNA-mediated knock-down of COX-2 in melanocytes suppresses melanogenesis | Q39364122 | ||
Use of self-delivery siRNAs to inhibit gene expression in an organotypic pachyonychia congenita model | Q39605490 | ||
Downregulation of monocyte chemoattractant protein-1 involving short interfering RNA attenuates hapten-induced contact hypersensitivity | Q40039657 | ||
Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf | Q40223081 | ||
A Wafer-Scale Etching Technique for High Aspect Ratio Implantable MEMS Structures | Q42016610 | ||
A microneedle roller for transdermal drug delivery | Q42972564 | ||
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells | Q45040403 | ||
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs | Q45147309 | ||
Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation. | Q45242278 | ||
Development of quantitative molecular clinical end points for siRNA clinical trials | Q46205464 | ||
Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery | Q46468179 | ||
Microneedle mediated delivery of nanoparticles into human skin. | Q47331967 | ||
Clinical administration of microneedles: skin puncture, pain and sensation. | Q47426250 | ||
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. | Q54326868 | ||
Nanocomposite-Strengthened Dissolving Microneedles for Improved Transdermal Delivery to Human Skin | Q61609395 | ||
Microfabricated microneedles: A novel approach to transdermal drug delivery | Q78232748 | ||
Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA | Q80805732 | ||
Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells | Q81227736 | ||
Oncogenic BRAF is required for tumor growth and maintenance in melanoma models | Q82310241 | ||
CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array | Q85258344 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 21422 | |
P577 | publication date | 2016-02-18 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Transdermal Delivery of siRNA through Microneedle Array | |
P478 | volume | 6 |
Q37380657 | An Improved Manufacturing Approach for Discrete Silicon Microneedle Arrays with Tunable Height-Pitch Ratio |
Q55280847 | Construction of histidine-containing hydrocarbon stapled cell penetrating peptides for in vitro and in vivo delivery of siRNAs. |
Q90452289 | Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo |
Q48331228 | Getting Drugs Across Biological Barriers. |
Q88626468 | Improving siRNA Delivery In Vivo Through Lipid Conjugation |
Q48531728 | Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles |
Q37125566 | Local administration of siRNA through Microneedle: Optimization, Bio-distribution, Tumor Suppression and Toxicity. |
Q51737325 | Oligonucleotide therapeutics in neurodegenerative diseases. |
Q47189515 | Recent Advances in Wearable Transdermal Delivery Systems |
Q47666014 | Recent advances of controlled drug delivery using microfluidic platforms. |
Q47990517 | The self-recovery of facial skin barrier and erythema after nanochip treatment |
Q64982493 | Tissue Interlocking Dissolving Microneedles for Accurate and Efficient Transdermal Delivery of Biomolecules. |
Q45325246 | siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease |
Search more.